Navigation Links
Anti-human CD41 Tetramer, 200 uL from StemCell Technologies, Inc.

ProductsAnti-human CD41 Tetramer, 200 uL from StemCell Technologies, Inc.
Company StemCell Technologies, Inc.
Item Anti-human CD41 Tetramer, 200 uL
Price 
Description This bispecific antibody complex has been tested for efficient depletion of CD41+ cells using the StemSep ; negative immunomagnetic cell separation system.
Info StemCell Technologies, Inc.StemCell Technologies, Inc.
570 West Seventh Avenue, Suite 400
Vancouver, BC, V5Z 1B3
Canada
Customer Service:
(604) 877-0713
(800) 667-0322

Fax Number:
(604) 877-0704
(800) 567-2899

Web Site: http://www.stemcell.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. StemSep CD45RA Tetramer, 100 uL from StemCell Technologies, Inc.
2. StemSep Anti-Human CD69 Tetramer, 200 uL from StemCell Technologies, Inc.
3. StemSep Anti-Hu HLA-DR Tetramer, 100 uL from StemCell Technologies, Inc.
4. StemSep Anti-Hu HLA-DR Tetramer, 200 uL from StemCell Technologies, Inc.
5. ALDEFLUOR, Stem Cell Identification, Kit from StemCell Technologies, Inc.
6. Mouse Oncostatin M from StemCell Technologies, Inc.
7. StemSep Hu-Mu Chimera Starter Kit, Kit from StemCell Technologies, Inc.
8. McCoys 5A Medium, 500 mL from StemCell Technologies, Inc.
9. BSA 10% Solution in Iscoves MDM, 100 mL from StemCell Technologies, Inc.
10. 4 channel Peristaltic pump, each from StemCell Technologies, Inc.
11. EasySep Biotin Selection Kit, Other from StemCell Technologies, Inc.
Phospho-mu-Opioid Receptor (Ser375) Antibody...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
... PhosphoSafe Extraction Reagent extracts cytosolic ... cells while preserving their phosphorylation ... of the CytoBuster Protein Extraction ... PhosphoSafe is compatible with Western ...
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Biology Products:
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/25/2015)... , June 25, 2015 ... Market by Type (Swipe & Area), Technology, Material (Optical ... Healthcare, Commercial Security & Others) & Geography - ... marketsandmarkets, the said market is expected to reach ... 17.1%. Browse 76 market Tables ...
(Date:6/24/2015)... , June 24, 2015 The biologics ... The major drivers for the market include growth of ... of new drug launches. Over the years, the number ... Between 2001 and 2010, the FDA approved 225 drug ... to WIPO, Europe accounted for ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... 31, 2008 Staying awake slows down our brains, scientists ... sleep but inevitably trends downward throughout the day, and sleep ... time, researchers at Washington University School of Medicine in St. ... When scientists genetically tweaked a part of the brain involved ...
... and his students have developed a nanomaterial that ... result in more fuel-efficient airplanes and cars as ... The material xGnP Exfoliated Graphite NanoPlatelets ... new and expanded applications in the aerospace, automotive ...
... New Zealand - Kiwifruit lovers can look forward to ... the release this week of crucial genetic data which ... varieties with increased health properties and exciting colours and ... HortResearch and listed New Zealand biotech company Genesis Research ...
Cached Biology News:Brain tweak lets sleep-deprived flies stay sharp 2'Small' research at MSU leads to advances in energy, electronics 2Genetic data promises new future for kiwi fruit 2Genetic data promises new future for kiwi fruit 3
(Date:6/30/2015)... June 30, 2015 /PRNewswire/ - Resverlogix Corp. ("Resverlogix") ... shares of Resverlogix have approved the resolutions relating ... Limited of 5,600,000 units at a price of ... unit being comprised of one common share and ... of approximately CAD$15 million; and (ii) the amendment ...
(Date:6/30/2015)... June 30, 2015  Today, Americord Registry, one of the ... Andrew Horne , a partner at Kirkland & Ellis LLP, ... Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We are ... Board," says Martin Smithmyer , CEO of Americord. "He ... career that will assist Americord,s growth and vision." ...
(Date:6/30/2015)... Oldsmar, FL (PRWEB) , ... June 30, 2015 , ... ... approximately 7.76% of Cryo-Cell’s currently outstanding common shares (including shares of unvested restricted stock). ... tender offer, the last sale price of Cryo-Cell’s shares reported on the OTCBB was ...
(Date:6/30/2015)... 30, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company focused on the development of autologous ... its Phase 1/2 clinical trial of RCT-01, being ... tendinosis, has been enrolled and their tissue biopsy ... RCT-01 is comprised of non-bulbar dermal sheath (NBDS) ...
Breaking Biology Technology:Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Americord Registry Announces Andrew Horne as Advisory Board Member 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4